Skip to main content
. 2015 Apr-Jun;11(42):327–336. doi: 10.4103/0973-1296.153086

Figure 1.

Figure 1

Effect of aluminium chloride (AlCl3) and AlCl3 + treatments (Rivastigmine, Sesamol) on (a) ELT time (latency to reach platform) (b) North-West (NW) latency (c) Percent time spent in target quadrant (NW). (d) Total zone entries and during retention trials before (day 5) and after (day 25, 45 and 65) treatment. Data presented as mean ± standard error of the mean (n = 8). *P < 0.05 as compared to control group and aP < 0.05 as compared to AlCl3 treated group